share_log

Both Retail Investors Who Control a Good Portion of Shinva Medical Instrument Co.,Ltd. (SHSE:600587) Along With Institutions Must Be Dismayed After Last Week's 3.8% Decrease

Both Retail Investors Who Control a Good Portion of Shinva Medical Instrument Co.,Ltd. (SHSE:600587) Along With Institutions Must Be Dismayed After Last Week's 3.8% Decrease

兩位散戶投資者都控制了信華醫療器械有限公司的很大一部分, Ltd.(上海證券交易所代碼:600587)以及各機構在上週下跌3.8%之後必須感到沮喪
Simply Wall St ·  01/10 18:09

Key Insights

關鍵見解

  • The considerable ownership by retail investors in Shinva Medical InstrumentLtd indicates that they collectively have a greater say in management and business strategy
  • A total of 10 investors have a majority stake in the company with 51% ownership
  • Institutions own 30% of Shinva Medical InstrumentLtd
  • 散戶投資者對Shinva Medical InstrumentLtd的大量所有權表明,他們在管理和業務戰略中共同擁有更大的發言權
  • 共有10名投資者持有該公司的多數股權,所有權爲51%
  • 機構擁有信華醫療器械有限公司30%的股份

Every investor in Shinva Medical Instrument Co.,Ltd. (SHSE:600587) should be aware of the most powerful shareholder groups. We can see that retail investors own the lion's share in the company with 35% ownership. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn).

信華醫療器械有限公司的每位投資者, Ltd.(上海證券交易所代碼:600587)應該知道最強大的股東群體。我們可以看到,散戶投資者擁有該公司的大部分股份,所有權爲35%。也就是說,如果股票上漲,該集團將受益最大(如果出現低迷,則損失最大)。

Following a 3.8% decrease in the stock price last week, retail investors suffered the most losses, but institutions who own 30% stock also took a hit.

繼上週股價下跌3.8%之後,散戶投資者遭受的損失最大,但擁有30%股票的機構也受到打擊。

Let's delve deeper into each type of owner of Shinva Medical InstrumentLtd, beginning with the chart below.

讓我們從下圖開始,深入研究Shinva Medical InstrumentLtd的每種類型的所有者。

See our latest analysis for Shinva Medical InstrumentLtd

查看我們對 Shinva Medical InstrumentLt 的最新分析

ownership-breakdown
SHSE:600587 Ownership Breakdown January 10th 2024
SHSE: 600587 所有權明細 2024 年 1 月 10 日

What Does The Institutional Ownership Tell Us About Shinva Medical InstrumentLtd?

關於 Shinva Medical InstrumentLtd,機構所有權告訴我們什麼?

Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing.

機構在向自己的投資者報告時通常會根據基準來衡量自己,因此,一旦股票被納入主要指數,他們通常會對股票更加熱情。我們預計大多數公司都會有一些機構在冊,尤其是在它們正在成長的情況下。

Shinva Medical InstrumentLtd already has institutions on the share registry. Indeed, they own a respectable stake in the company. This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. If multiple institutions change their view on a stock at the same time, you could see the share price drop fast. It's therefore worth looking at Shinva Medical InstrumentLtd's earnings history below. Of course, the future is what really matters.

Shinva Medical InstrumentLtd已經在股票登記處設立了機構。事實上,他們擁有該公司可觀的股份。這意味着在這些機構工作的分析師已經看過這隻股票,他們很喜歡。但是就像其他人一樣,他們可能錯了。如果多家機構同時改變對股票的看法,你可能會看到股價快速下跌。因此,值得在下面查看Shinva Medical InstrumentLtd的收益記錄。當然,未來才是真正重要的。

earnings-and-revenue-growth
SHSE:600587 Earnings and Revenue Growth January 10th 2024
SHSE: 600587 收益和收入增長 2024 年 1 月 10 日

We note that hedge funds don't have a meaningful investment in Shinva Medical InstrumentLtd. China National Nuclear Power Co., Ltd. is currently the company's largest shareholder with 29% of shares outstanding. For context, the second largest shareholder holds about 4.5% of the shares outstanding, followed by an ownership of 4.1% by the third-largest shareholder.

我們注意到,對沖基金對Shinva Medical InstrumentLtd沒有進行有意義的投資。中國核電股份有限公司目前是該公司的最大股東,已發行股份的29%。就背景而言,第二大股東持有約4.5%的已發行股份,其次是第三大股東持有4.1%的所有權。

We also observed that the top 10 shareholders account for more than half of the share register, with a few smaller shareholders to balance the interests of the larger ones to a certain extent.

我們還觀察到,前十名股東佔股票登記冊的一半以上,少數規模較小的股東可以在一定程度上平衡大股東的利益。

While it makes sense to study institutional ownership data for a company, it also makes sense to study analyst sentiments to know which way the wind is blowing. Quite a few analysts cover the stock, so you could look into forecast growth quite easily.

雖然研究公司的機構所有權數據是有意義的,但研究分析師的情緒以了解風向哪個方向吹來也是有意義的。有不少分析師報道了該股,因此你可以很容易地研究預測的增長。

Insider Ownership Of Shinva Medical InstrumentLtd

Shinva 醫療器械有限公司的內部所有權

The definition of an insider can differ slightly between different countries, but members of the board of directors always count. The company management answer to the board and the latter should represent the interests of shareholders. Notably, sometimes top-level managers are on the board themselves.

不同國家對內部人士的定義可能略有不同,但董事會成員總是計算在內。公司管理層對董事會的回答,董事會應代表股東的利益。值得注意的是,有時高層管理人員自己也在董事會中。

Most consider insider ownership a positive because it can indicate the board is well aligned with other shareholders. However, on some occasions too much power is concentrated within this group.

大多數人認爲內部所有權是積極的,因爲這可能表明董事會與其他股東關係良好。但是,在某些情況下,過多的權力集中在該群體中。

Our most recent data indicates that insiders own less than 1% of Shinva Medical Instrument Co.,Ltd.. But they may have an indirect interest through a corporate structure that we haven't picked up on. Keep in mind that it's a big company, and the insiders own CN¥23m worth of shares. The absolute value might be more important than the proportional share. It is good to see board members owning shares, but it might be worth checking if those insiders have been buying.

我們的最新數據顯示,內部人士擁有信華醫療器械有限公司不到1%的股份。,有限公司。但是,他們可能會通過我們尚未採用的公司結構獲得間接利益。請記住,這是一家大公司,內部人士擁有價值2300萬元人民幣的股票。絕對值可能比比例份額更重要。很高興看到董事會成員擁有股票,但可能值得檢查一下這些內部人士是否在買入。

General Public Ownership

一般公有制

The general public, who are usually individual investors, hold a 35% stake in Shinva Medical InstrumentLtd. While this group can't necessarily call the shots, it can certainly have a real influence on how the company is run.

公衆通常是個人投資者,持有信華醫療器械有限公司35%的股份。儘管這個群體不一定能做主,但它肯定會對公司的運作方式產生真正的影響。

Private Company Ownership

私人公司所有權

It seems that Private Companies own 5.4%, of the Shinva Medical InstrumentLtd stock. It's hard to draw any conclusions from this fact alone, so its worth looking into who owns those private companies. Sometimes insiders or other related parties have an interest in shares in a public company through a separate private company.

私人公司似乎擁有信華醫療器械有限公司5.4%的股份。僅憑這一事實很難得出任何結論,因此值得研究誰擁有這些私營公司。有時,內部人士或其他關聯方通過一家獨立的私人公司對上市公司的股份擁有權益。

Public Company Ownership

上市公司所有權

It appears to us that public companies own 29% of Shinva Medical InstrumentLtd. This may be a strategic interest and the two companies may have related business interests. It could be that they have de-merged. This holding is probably worth investigating further.

在我們看來,上市公司擁有信華醫療器械有限公司29%的股份。這可能是戰略利益,兩家公司可能有相關的商業利益。可能是他們已經消失了。這一裁定可能值得進一步調查。

Next Steps:

後續步驟:

It's always worth thinking about the different groups who own shares in a company. But to understand Shinva Medical InstrumentLtd better, we need to consider many other factors. For instance, we've identified 2 warning signs for Shinva Medical InstrumentLtd that you should be aware of.

擁有公司股份的不同群體總是值得考慮的。但是,爲了更好地了解Shinva Medical InstrumentLtd,我們需要考慮許多其他因素。例如,我們已經確定了Shinva Medical InstrumentLtd的兩個警告信號,你應該注意這些信號。

If you are like me, you may want to think about whether this company will grow or shrink. Luckily, you can check this free report showing analyst forecasts for its future.

如果你像我一樣,你可能需要考慮這家公司是會成長還是會萎縮。幸運的是,您可以查看這份免費報告,其中顯示了分析師對其未來的預測。

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

注意:本文中的數字是使用過去十二個月的數據計算得出的,這些數據是指截至財務報表日期當月最後一天的12個月期間。這可能與全年年度報告數據不一致。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論